For example, traditional urate-lowering therapies such as xanthine oxidase inhibitors (e.g., allopurinol or febuxostat) effectively reduce serum urate production, while biologics like anakinra inhibit IL-1β, targeting inflammation directly during acute gout flares [70]. Here, XDH is linked to gout.